Winship Cancer Institute of Emory University is a nonprofit cancer research and patient care center based in Atlanta, Georgia. Winship Cancer Institute is the only National Cancer Institute-designated Comprehensive Cancer Center in Georgia.

There are 587 beds in Emory Hemo Comp Evaluation Clinic / East TN Comp Hemo Ctr.

During the past decade, Emory Hemo Comp Evaluation Clinic / East TN Comp Hemo Ctr conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Emory Hemo Comp Evaluation Clinic / East TN Comp Hemo Ctr" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Glaxo Wellcome" with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "Washington University School of Medicine" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Emory Hemo Comp Evaluation Clinic / East TN Comp Hemo Ctr" are "HIV Infections" (7 trials), "Candidiasis, Oral" (1 trials) and "Mycobacterium Avium-intracellulare Infection" (1 trials). Many other conditions were trialed in "Emory Hemo Comp Evaluation Clinic / East TN Comp Hemo Ctr" in a lesser frequency.

Most popular intervention types in "Emory Hemo Comp Evaluation Clinic / East TN Comp Hemo Ctr" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Indinavir sulfate" (3 trials), "Zidovudine" (3 trials), "Abacavir sulfate" (2 trials), "Amprenavir" (2 trials) and "Didanosine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Emory Hemo Comp Evaluation Clinic / East TN Comp Hemo Ctr" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Emory Hemo Comp Evaluation Clinic / East TN Comp Hemo Ctr". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Emory Hemo Comp Evaluation Clinic / East TN Comp Hemo Ctr, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Emory Hemo Comp Evaluation Clinic / East TN Comp Hemo Ctr, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".